dihydroergotamine (Strategic Science & Technologies)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namedihydroergotamine (Strategic Science & Technologies)
Drug Alias NameDHE (Strategic Science & Technologies)dihydroergotamineSST-8055
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1d (5-HT1d) receptor agonists
TargetsSerotonin 1d (5-HT1d) receptor
Therapy Area/IndicationsMigraine Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesStrategic Science & Technologies Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesStrategic Science & Technologies Llc
Active IndicationsN/A
Inactive IndicationsMigraine Disorders

Other Information

ATC CodeN/A
Related LinksN/A